Genetic and epigenetic changes in mammary epithelial cells identify a subpopulation of cells involved in early carcinogenesis

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 70, Issue , 2005, Pages 317-327

  Berman, H ^a   Zhang, J ^a   Crawford, Y G ^a   Gauthier, M L ^a   Fordyce, C A ^a   McDermott, K M ^a   Sigaroudinia, M ^a   Kozakiewicz, K ^a   Tlsty, T D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; PROTEIN P16INK4A; PROTEIN P16;

APOPTOSIS; BREAST CARCINOMA; BREAST CELL; BREAST EPITHELIUM; CARCINOGENESIS; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL MIGRATION; CELL SUBPOPULATION; CELL SURVIVAL; CONFERENCE PAPER; EARLY CANCER; EPITHELIUM CELL; GENE ACTIVITY; GENE EXPRESSION; GENE INACTIVATION; GENETIC EPIGENESIS; GENOMIC INSTABILITY; HUMAN; IMMUNOSURVEILLANCE; IN VITRO STUDY; INTRADUCTAL CARCINOMA; MUTAGENICITY; NEOPLASM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ARTICLE; BREAST EPITHELIUM CELL; CELL PROLIFERATION; CYTOGENETICS; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; PHENOTYPE;

BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CENTROSOME; DNA METHYLATION; EPIGENESIS, GENETIC; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE SILENCING; GENES, P16; GENOMIC INSTABILITY; HUMANS; MODELS, BIOLOGICAL; PROMOTER REGIONS (GENETICS); TELOMERE;

EID: 33746433463     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2005.70.051     Document Type: Conference Paper

References (63)

1. Alpers C.E. and Wellings S.R. 1985. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum. Pathol. 16: 796.
2. Band V. and Sager R. 1989. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that support long-term growth of both cell types. Proc. Natl. Acad. Sci. 86: 1249.
3. Bandyopadhyay G.K., Imagawa W., Wallace D., and Nandi S. 1987. Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor. J. Biol. Chem. 262: 2750.
4. Baylin S.B. and Herman J.G. 2000. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet. 4: 168.
5. Benanti J.A. and Galloway D.A. 2004. Normal human fibroblasts are resistant to RAS-induced senescence. Mol. Cell. Biol. 24: 2842.
6. Berg J.W. and Hutter R.V. 1995. Breast cancer. Cancer 75: 257.
7. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349.
8. Boveri T. 1914. Zur Frage der Entstehung maligner Tumoren, vol. 4, p. 64. Gustav Fischer, Jena, Germany.
9. Boveri T.and Boveri M. 1929. The origin of malignant tumors. Williams and Wilkins, Baltimore, Maryland.
10. Brenner A.J., Stampfer M.R., and Aldaz C.M. 1998. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17: 199.
11. Burbano R.R., Mederios A., deAmorin M.I., Lima E.M., Mello A., Neto J.B., and Casartelli C. 2000. Cytogenetics of epithelial hyperplasias of the human breast. Cancer Genet. Cytogenet. 119: 62.
12. Cairns P., Mao L., Merlo A., Lee D.J., Schwab D., Eby Y., Tokino K., Van der Riet P., Blaugrund J.E., and Sidransky D. 1994. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265: 415.
13. Crawford Y.G., Gauthier M.L., Joubel A., Mantei K., Kozakiewicz K., Afshari C.A., and Tlsty T.D. 2004. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell 5: 263.
14. Deng G., Lu Y., Zlotnikov G., Thor A.D., and Smith H.S. 1996. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057.
15. Duensing S. 2005. A tentative classification of centrosome abnormalities in cancer. Cell Biol. Int. 29: 352.
16. Foster S.A. and Galloway D.A. 1996. Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene 12: 1773.
17. Foster S.A., Wong D.J., Barrett M.T., and Galloway D.A. 1998. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18: 1793.
18. Gately S. 2000. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 19: 19.
19. Gonzalez-Zulueta M., Bender C.M., Yang A.S., Nguyen T., Beart R.W., Van Tornout J.M., and Jones P.A. 1997. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppresor gene in normal and transformed human tissue correlates with gene silencing. Cancer Res. 55: 4531.
20. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., and Weinberg R.A. 1999. Creation of human tumor cells with defined genetic elements. Nature 400: 464.
21. Hammond S.L., Ham R.G., and Stampfer M.R. 1984. Serum-free growth of human mammary epithelial cells: Rapid clonal growth in defined medium and extended passage with pituitary extract. Proc. Natl. Acad. Sci. 81: 5435.
22. Harris R.E., Robertson F.M., Abou-Issa H.M., Farrar W.B., and Brueggemeier R. 1999. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): An extension of the dietary fat hypothesis of breast cancer. Med. Hypotheses 52: 291.
23. Hayflick L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37: 614.
24. Herman, J.G., Graff, J.R., Myöhänen S., Nelkin B.D., and Baylin S.B. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. 93: 9821.
25. Herman J.G., Civin C.I., Issa J.P., Collector M.I., Sharkis S.J., and Baylin S.B. 1997. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 57: 837.
26. Holst C.R., Nuovo G.J., Esteller M., Chew K., Baylin S.B., Herman J.G., and Tlsty T.D. 2003. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63: 1596.
27. Howe L.R., Subbaramaiah K., Brown A.M., and Dannenberg A.J. 2001. Cyclooxygenase-2: A target for the prevention and treatment of breast cancer. Endocr. Relat. Cancer 8: 97.
28. Huang M., Stolina M., Sharma S., Mao J.T., Zhu L., Miller P.W., Wollman J., Herschmann D., and Dubinett S.M. 1998. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res. 58: 1208.
29. Huschtscha L.I., Noble J.R., Neumann A.A., Moy E.L., Barry P., Melki J.R., Clark S.J., and Reddel R.R. 1998. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res. 58: 3508.
30. Jiang X.R., Jimenez G., Chang E., Frolkis M., Kusler B., Sage M., Beeche M., Bodnar A.G., Wahl GM., Tlsty T.D., and Chiu C.P. 1999. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21: 111.
31. Kao C.Y., Nomata K., Oakley C.S., Welsh C.W., and Chang C.C. 1995. Two types of normal human breast epithelial cells derived from reduction mammoplasty: Phenotypic characterization and response to SV40 transfection. Carcinogenesis 16: 531.
32. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., and Klingelhutz A.J. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84.
33. Krinferpot P., Quon K.C., Mooi W.J, Loonstra A., and Berns A. 2001. Loss of p16 Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413: 83.
34. Lakhani S.R., Chaggar R., Davies S., Jones C., and Collins N. 1999. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J. Pathol. 189: 496.
35. Larson P.S., de las Morenas A., Bennett S.R., Cupples L.A., and Rosenberg C.L. 2002. Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am. J. Pathol. 161: 283.
36. Larson P.S., de las Morenas A., Cupples L.A., Huang K., and Rosenberg C.L. 1998. Genetically abnormal clones in histologically normal breast tissue. Am. J. Pathol. 152: 1591.
37. Li Z., Moore D.H., Meng Z.H., Ljung B.M., and Gray J.W. 2002. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. Cancer Res. 62: 1000.
38. Lingle W.L. and Salisbury J.L. 1999. Altered centrosome structure is associated with abnormal mitosis in human breast tumors. Am. J. Pathol. 155: 1941.
39. Lingle W.L., Barrett S.L., Negron V.C., D'Assoro A.B., and Boeneman K. 2002. Centrosome and amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. 99: 1978.
40. Lingle W.L., Lutz W.H., Ingle J.N., Maihle N.J, and Salisbury J.L. 1998. Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity. Proc. Natl. Acad. Sci. 95: 2950.
41. Liu X.H., Yao S., Kirschenbaum A., and Levine A.C. 1998. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res. 58: 4245.
42. Luria S.E. and Delbrück M. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28: 491.
43. Medema R.H., Herrera R.E., Lam F., and Weinberg R.A. 1995. Growth suppression by p16INK4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. 92: 6289.
44. Nielsen M., Thomsen J.L., Primdahl S., Dyreborg U., and Andersen J.A. 1987. Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies. Br. J. Cancer 56: 814.
45. Nguyen C., Liang G., Nguyen T.T., Tsao-Wei D., Groshen S., Lübbert M., Zhou J.H., Benedict W.F., and Jones P.A. 2001. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J. Natl. Cancer Inst. 93: 1465.
46. Nuovo G.J., Plaia T.W., Belinsky S.A, Baylin S.B., and Herman J.G. 1999. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl. Acad. Sci. 96: 12754.
47. Pandis N. 1995. Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors. Cancer 76: 250.
48. CDKN2 associated with familial melanoma. Mol. Cell. Biol. 16: 3844.
49. Ramirez R.D., Morales C.P., Herbert B.S., Rohde J.M., Passons C., Shay J.W., and Wright W.E. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15: 398.
50. Romanov S.R., Kozakiewicz B.K., Holst C.R., Stampfer M.R., Haupt L.M., and Tlsty T.D. 2001. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409: 633.
51. Salisbury J.L. 2001. The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer. J. Mammary Gland Biol. Neoplasia 6: 203.
52. Serrano M., Hannon G.J, and Beach D. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704.
53. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H, Aguirre A.J., Wu E.A., Horner J.W., and DePinho R.A. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413: 86.
54. Shim V., Gauthier M.L., Sudilovsky D., Mantei K., Chew K.L., Moore D.H., Cha I., Tlsty T.D., and Esserman L.J. 2003. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium. Cancer Res. 63: 2347.
55. INK4a(-) human mammary epithelial cells. Proc. Natl. Acad. Sci. 98: 4498.
56. Taylor-Papadimitriou J., Stampfer M., Bartek J., Lewis A., Boshell M., Lane E.B., and Leigh I.M. 1989. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: Relation to in vivo phenotypes and influence of medium. J. Cell Sci. 94: 403.
57. Tlsty T.D., Margolin B.H., and Lum K. 1989. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. Proc. Natl. Acad. Sci. 86: 9441.
58. Tlsty T.D., Romanov S.R., Kozakiewicz B.K., Holst C.R., Haupt L.M., and Crawford Y.G. 2001. Loss of chromosomal integrity in human mammary epithelial cells subsequent to escape from senescence. J. Mammary Gland Biol. Neoplasia 6: 235.
59. Tlsty T.D., Crawford Y.G., Holst C.R., Fordyce C.A., Zhang J., McDermott K., Kozakiewicz K., and Gauthier M.L. 2004. Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis. J. Mammary Gland Biol. Neoplasia 9: 263.
60. Van Steensel B., Smogorzewska A., and de Lange T. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401.
61. Walen K.H. and Stampfer M.R. 1989. Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. Cancer Genet. Cytogenet. 37: 249.
62. Welch H.G. and Black W.C. 1997. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: How much more breast cancer can we find? Ann. Intern. Med. 127: 1023.
63. Yang R., Serrano M., Slater J., Leung E., and Koeffler H.P. 1996. Analysis of p16INK4a and its interaction with CDK4. Biochem. Biophys. Res. Commun. 218: 254.